Abstract
Cancer therapeutics–related cardiac dysfunction was defined as a decrease in the left ventricular ejection fraction of >10 percentage points, to a value <53%, in
a recent expert consensus document (1). Clinically, early prediction of cardiotoxicity in patients receiving chemotherapy may be useful for defining an
optimal strategy to prevent ventricular functional impairment.
Original language | English |
---|---|
Pages (from-to) | 881-882 |
Number of pages | 2 |
Journal | JACC: Cardiovascular Imaging |
Volume | 13 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2020 |
Keywords
- letter
- letter to the editor
- short communication
- Meta-Analysis
- Chemotherapy-Treated Patients
- Prediction of Cardiotoxicity
- Echocardiography
- Myocardial Strain Imaging